YPSN.SW - Ypsomed Holding AG

Swiss - Swiss Delayed Price. Currency in CHF

Ypsomed Holding AG

Brunnmattstrasse 6
Burgdorf 3401
41 34 424 41 11

IndustryMedical Instruments & Supplies
Full Time Employees1,627

Key Executives

NameTitlePayExercisedYear Born
Mr. Simon MichelChief Exec. Officer668.1kN/A1977
Mr. Niklaus RamseierChief Financial OfficerN/AN/A1963
Mr. Frank MengisCOO & Sr. VP of OperationsN/AN/A1964
Mr. Hans-Ulrich LehmannSr. VP of Technology & CTON/AN/A1966
Thomas KuttHead of Investor RelationsN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CHF.


Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through Ypsomed Delivery Systems and Ypsomed Diabetes Care segments. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. The company operates in Switzerland, other European countries, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

Corporate Governance

Ypsomed Holding AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.